Let’s Connect at ECSMID Global 2026
DNAe will be attending and presenting new data at ECSMID Global 2026 – the Congress of the European Society of Clinical Microbiology and Infectious Diseases.
ESCMID Global 2026 is one of the leading international congresses for infectious diseases and clinical microbiology, bringing together researchers, clinicians and diagnostic innovators to share the latest scientific advances. It’s an ideal moment to meet with our team, who will be on-site presenting new data from DNAe’s next‑generation sequencing‑based diagnostic platform – including performance insights, workflow advances and real‑world applicability for rapid pathogen detection.
Event Details
Conference: ESCMID Global 2026
Dates: April 17–21 2026
Location: Munich, Germany
Conference website: https://www.escmid.org/congress-events/escmid-global/munich-2026/
DNAe posters and oral session
At ESCMID Global 2026, we’ll be presenting brand-new data on our LiDia‑SEQ™ platform and our breakthrough sample‑to‑result NGS‑based diagnostics across three key presentations:
Oral Session
Title: The world’s first direct from raw sample to report NGS platform: delivering rapid BSI pathogen ID and AMR from whole blood clinical samples
Date: 21 April 2026
Time: 13:30
Location: Hall ICM 5
Poster Session
Title: Exploring the gains: potential economic impact of a rapid, direct from whole-blood-to-report NGS-based diagnostic platform (LiDia-SEQTM) for BSI detection
Date/Time: tbc
Title: An assay for the detection of sepsis pathogens directly from whole blood samples
Date/Time: tbc
When
April 17–21 2026
Where
Munich, Germany
Conference website
https://www.escmid.org/congress-events/escmid-global/munich-2026/
Meet us in Munich
ESCMID Global 2026 offers a strong opportunity for deeper technical discussions and collaboration. If you’re attending the conference, we’d welcome the chance to meet.
Your Opportunity To Connect With
Sam Reed
CEO
Rishi Joshi
VP Product Management
and Business Development
